Publications by authors named "Sobieszczyk S"

Objective: The primary pathologic reason for thrombotic thrombocytopenic purpura (TTP) lies in the systemic formation of platelet aggregations in association with endothelial cells damage. Endothelial damage is a result of an abnormal synthesis and metabolism of unusually large von Willebrand Factor (ULvWF) multimers. In normal conditions vWF cleaving metalloprotease, known as ADAMTS-13 (A Disintegrin And Metalloproteinase with Thrombospondin type-1 motif, member 13) prevents the ULvWF entrance in the circulation.

View Article and Find Full Text PDF
Article Synopsis
  • Exsanguination is a significant yet often overlooked factor leading to treatment failures in trauma and surgical patients, particularly those without prior blood clotting disorders.
  • The study aimed to evaluate the effectiveness of various interdisciplinary treatment strategies based on expert opinions regarding massive bleeding.
  • Key findings highlight that severe blood loss, excessive fluid therapy, and inadequate blood product administration increase the risk of post-hemorrhagic coagulopathy, while treatments like antifibrinolytic drugs and specific coagulation factor concentrates are recommended for effective management.
View Article and Find Full Text PDF
Article Synopsis
  • During pregnancy, increased coagulation factor levels create a "physiological" hypercoagulability, beneficial for preventing hemorrhage during delivery but raising the risk of venous thrombosis.
  • Antithrombin, a key inhibitor of coagulation, can become deficient due to various conditions, leading to increased thrombosis risk, either acquired or inherited.
  • The study discusses the case of a pregnant woman with deep vein thrombosis and antithrombin deficiency while examining the potential benefits of routine antithrombin testing and supplementation, especially for obese women, highlighting the lack of established guidelines for treatment.
View Article and Find Full Text PDF

Thrombophilia is a congenital or acquired disorder of haemostatic imbalance leading to clot formation. Congenital thrombophilia is a result of different genetic polymorphisms in the genes coding for particular elements in coagulation and fibrinolysis processes and is connected with excessive readiness to thrombosis in the carriers the mutated alleles. A higher coagulation activity has been observed in case of pregnant women who are carriers of congenital thrombophilia, when compared to the pre-pregnancy activity.

View Article and Find Full Text PDF

Background: This paper presents an analysis of 25 patient cases in which recombinant factor VIIa was used in the management of postpartum hemorrhage, including severe and/or life-threatening bleeds. Anecdotal experiences in the empirical use of this agent are described and dosing regimens, effects on bleeding, and safety data are presented.

Methods: Data were extracted from the international, internet-based, voluntary registry, haemostasis.

View Article and Find Full Text PDF
Article Synopsis
  • Perinatal bleeding can result in fatal outcomes in about 10% of cases, highlighting the seriousness of the condition.
  • A 29-year-old woman successfully received recombinant activated factor VII during surgery to control severe bleeding after a cesarean section and hysterectomy.
  • The use of rFVIIa allowed for rapid control of hemorrhage, enabling safe identification of the source of bleeding without significant clotting issues post-surgery, suggesting its effectiveness in treating life-threatening obstetrical hemorrhages.
View Article and Find Full Text PDF

Opiates have been reported to suppress POMC in the medial basal hypothalamus (MBH) but studies have been complicated by the fact that acutely, in the rat, opiates stimulate corticosterone and inhibit gonadal steroid release, which could both affect POMC in brain. We have therefore examined POMC gene expression and peptide levels in the MBH of castrated rats after 10 days of treatment with subcutaneous morphine or placebo pellets and after pellet removal. POMC mRNA was measured by solution hybridization assay and beta-endorphin (beta-EP) and alpha-MSH were measured by RIA.

View Article and Find Full Text PDF

Previous studies have shown that chronic opioid receptor blockade has significant effects on POMC gene expression and peptide levels in the hypothalamus. We have now examined the effects of the opioid antagonist naltrexone on beta-EP processing in the hypothalamus and on the release of 2 POMC-derived peptides, beta-EP and gamma 3-MSH, from the perifused hypothalamus in vitro. The beta-EP immunoactivity in the medial basal hypothalamus (MBH) of 7 rats infused for 1 week with naltrexone by osmotic minipump, was individually analyzed by HPLC and compared to 7 control rats.

View Article and Find Full Text PDF

Serum TSH and PRL levels and their response to TRH were measured in 11 patients with generalized resistance to thyroid hormone (GRTH), 6 euthyroid subjects, and 6 patients with primary hypothyroidism. TSH and PRL levels and their response to TRH were also measured after the consecutive administration of 50, 100, and 200 micrograms T3 daily, each for a period of 3 days. Using a sensitive TSH assay, all GRTH patients had TSH values that were elevated or within the normal range.

View Article and Find Full Text PDF

A form of thyroxine-binding globulin (TBG) with reduced affinity for hormone and increased susceptibility to heat and acid denaturation has been identified in Australian Aborigines (TBG-A). Results of heat denaturation of TBG established that the TBGA allele is X linked and has a frequency of 50.9% in Western Australian Aborigines.

View Article and Find Full Text PDF

We investigated the pattern of GH secretion in response to repetitive TRH administration in patients with active acromegaly and in normal subjects. Nine acromegalic patients and 10 normal subjects received three doses of 200 micrograms of TRH iv at 90-min intervals. There was a marked serum GH rise in acromegalic patients after each TRH dose (net incremental area under the curve [nAUC]: first dose = 4448 +/- 1635 micrograms.

View Article and Find Full Text PDF

In the present study we investigated the nature of somatoliberin-like immunoreactivity in human seminal plasma. In unextracted seminal plasma, somatoliberin-like immunoreactivity represented 3.8 micrograms/l somatoliberin, with a dilution curve that ran almost completely parallel to that of synthetic somatoliberin standard.

View Article and Find Full Text PDF

Continuous infusion or pulsatile administration of growth hormone releasing factor leads to decreasing GH levels and GH responses in normal subjects. We have given 50 micrograms GRF 1-44 i.v.

View Article and Find Full Text PDF

The influence of the medium collected from cultured rat Sertoli cells on the spontaneous and LHRH-stimulated release of gonadotropins by incubated rat pituitary halves was examined. The homogeneity of the cultured population of Sertoli cells taken from 20-day-old rats ranged up to 98%. The cells in culture responded to FSH stimulation with characteristic morphological changes and with increased secretion of estradiol-17 beta.

View Article and Find Full Text PDF